No, they weren’t really. They hardly had any apps - or, more generally, dependent (third-party) apps or services - that ran on them. Which is why they failed vs. operating systems that successfully established platform status and rich ecosystems depending on them.
Coming back to your question:
They’re more like desktop application software. You’re making the case yourself:
MS Office has macros and APIs that interface with it. Photoshop has… plugins, but they’re arguably less of an “ecosystem” platform as MS Windows or iOS.
The key to picking software stocks and identifying companies with viable long-term business models is their strength as a platform and in ecosystem that makes them hard to replace.
In your view what are required elements to be a platform and why is windows one and symbian not. Because your view doesn’t seem to accord with normal definitions.
Cool you watched the video, although a bit too alarmist in my opinion there is probably a lot of truth. Best part, I learnt a new economical term: “rentier capitalism”. I was aware about this trend of milking your customer on a monthly basis but was not aware of the extent. Seems like Adobe stated this trend back in 2013 based on that video. More worrying is that this not motivate the company to innovate much.
So the question for ADBE is probably more how long can they continue with these good numbers…
Why should they buy a dying business?
I was more thinking of a company like Bending Spoons. But probably the price of Adobe would have to go down a bit more for them to be able to afford such a purchase.
DRAM is a semi conductor ETF, it holds Smsung and all the other guys, i use it to gain exposure overall without havin single stock exposure.
SLS is the current hype over the web, i am not sure for now if it is a play to follow trough or not.
Apparently they have a cancer treatment in experimental phase (2?) where people would normally live 6 months. The trial started 2 years ago and from the 80 patients 2 are still alive.
Once all have passed away they can publish the data. The overall consens is that since 2 years is longer than 6 month the drug should work.
You may want to follow through, as long as you’re confident in placing bets on a roulette table.
Or you expertise in early-stage cancer drug development.
Mit dem Lesen und der Teilnahme an diesem Forum bestätigst du, dass du die Forum-Richtlinien gelesen hast und damit einverstanden bist sowie den Haftungsausschluss auf http://www.mustachianpost.com/de/ akzeptierst.